ASH 2025: New combination approach aims to make CAR T more durable in lymphoma
A new clinical trial suggests that pairing bispecific antibodies and antibody-drug conjugates with CAR T-cell…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
ASH 2025: ‘Ready-made’ T-cell gene therapy tackles ‘incurable’ T-cell leukaemia
A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College…
Small team, big impact: Automation helps relieve symptoms to keep cancer patients out of the ER
For many people living with cancer, symptoms such as pain, anxiety, or insomnia can quickly…
SABCS 2025: Simple blood tests could help tailor treatment for aggressive breast cancer
Australian-led research has shown that a series of blood tests to detect ‘circulating tumour DNA’…
The future of cancer detection could be just a blood test away
The prospect of diagnosing cancer through painless methods—such as a simple AI-assisted blood or urine…
An overlooked hormone eyed as deadly driver of postmenopausal breast cancer in women with obesity
A new analysis of research into the most common type of breast cancer has zeroed…
Light-sensitive microbial protein may herald new cancer therapies
One of the hallmarks of cancer cells is their ability to evade apoptosis, or programmed…
A simple urine test could revolutionise bladder cancer diagnosis and treatment
Researchers have discovered that analysing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple…
Breakthrough trial reveals promising therapy for aggressive brain cancer
Huntsman Cancer Institute at the University of Utah, USA, participated in a clinical trial that…
Chemists synthesise a fungal compound that holds promise for treating brain cancer
For the first time, MIT chemists have synthesised a fungal compound known as verticillin A,…